Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation

MLA

D. Kyle Hogarth, et al. “Comprehensive Genetic Testing Identifies Targetable Genomic Alterations in Most Patients with Non-Small Cell Lung Cancer, Specifically Adenocarcinoma, Single Institute Investigation.” Oncotarget, vol. 7, no. 14, Feb. 2016, pp. 18876–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....70384ca37e416a154baf821363b80889&authtype=sso&custid=ns315887.

APA

D. Kyle Hogarth, Septimiu Murgu, Brian Won, Mark K. Ferguson, Thomas A. Hensing, Everett E. Vokes, Aliya N. Husain, Wickii T. Vigneswaran, Philip C. Hoffman, Ravi Salgia, Cassie A. Simon, Heber MacMahon, Kathryn Alexa Patton, Jeffrey Mueller, Janani Vigneswaran, Christopher H. Wigfield, Victoria M. Villaflor, Yi-Hung Carol Tan, & Renuka Malik. (2016). Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget, 7(14), 18876–18886.

Chicago

D. Kyle Hogarth, Septimiu Murgu, Brian Won, Mark K. Ferguson, Thomas A. Hensing, Everett E. Vokes, Aliya N. Husain, et al. 2016. “Comprehensive Genetic Testing Identifies Targetable Genomic Alterations in Most Patients with Non-Small Cell Lung Cancer, Specifically Adenocarcinoma, Single Institute Investigation.” Oncotarget 7 (14): 18876–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....70384ca37e416a154baf821363b80889&authtype=sso&custid=ns315887.